Filing Flows › C4 Therapeutics (CCCC) › How it makes money
How C4 Therapeutics (CCCC) makes money
C4 Therapeutics (CCCC) made $8.5M of revenue in the third quarter 2026 (Q3 2026), -25% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $8.5M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $8.5M | -25% |
| Q2 2026 | $6.6M | +3% |
| Q1 2026 | $6.2M | -15% |
| Q4 2025 | $11.0M | +113% |
| Q3 2025 | $11.2M | -27% |
| Q2 2025 | $6.5M | -46% |
| Q1 2025 | $7.2M | +138% |
From C4 Therapeutics' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does C4 Therapeutics make money?
C4 Therapeutics (CCCC) made $8.5M of revenue in the third quarter 2026 (Q3 2026), -25% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.